Average Co-Inventor Count = 4.92
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (32 from 3,681 patents)
2. American Cyanamid Company (2 from 3,580 patents)
34 patents:
1. 9102599 - N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
2. 8642576 - Heterocyclic CETP inhibitors
3. 8404896 - N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
4. 8304403 - Heterocyclic CETP inhibitors
5. 7888376 - Heterocyclic CETP inhibitors
6. 7790770 - Heterocyclic CETP inhibitors
7. 7776859 - Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function
8. 7655688 - Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
9. 7655689 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10. 7550458 - Tricycloundecane compounds useful as modulators of nuclear hormone receptor function
11. 7517904 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
12. 7470797 - Fused heterocyclic imido and amido compounds
13. 7468439 - Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function
14. 7432267 - Fused cyclic modulators of nuclear hormone receptor function
15. 7342034 - Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function